Copyright
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Apr 14, 2025; 31(14): 102943
Published online Apr 14, 2025. doi: 10.3748/wjg.v31.i14.102943
Published online Apr 14, 2025. doi: 10.3748/wjg.v31.i14.102943
Chinese patent medicine: Opening new perspectives for treatment of post-endoscopic submucosal dissection esophageal stricture in esophageal cancer patients
Jie-Yu Guo, School of Life and Health Sciences, Institute of Biomedical Research, Wuhan 430068, Hubei Province, China
Xue-Ying Dong, Shi Li, Jing-Feng Tang, Ce-Fan Zhou, National "111" Center for Cellular Regulation and Molecular Pharmaceutics, School of Life and Health Sciences, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of Technology, Wuhan 430068, Hubei Province, China
Author contributions: Guo JY wrote the original draft; Guo JY and Zhou CF participated in drafting the manuscript; Dong XY, Li S, and Tang JF provided some opinions; Zhou CF contributed to conceptualization, writing, reviewing, and editing; all authors have read and approved the final manuscript.
Supported by National Natural Science Foundation of China, No. 82370715, No. 32270768, and No. 82273970; National Key R and D Program of China, No. 2023YFC2507904; and Innovation Group Project of Hubei Province, No. 2023AFA026.
Conflict-of-interest statement: The authors declare no conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ce-Fan Zhou, PhD, Professor, National "111" Center for Cellular Regulation and Molecular Pharmaceutics, School of Life and Health Sciences, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of Technology, No. 28 Nanli Road, Wuhan 430068, Hubei Province, China. cefan@hbut.edu.cn
Received: November 4, 2024
Revised: February 28, 2025
Accepted: March 10, 2025
Published online: April 14, 2025
Processing time: 159 Days and 13.9 Hours
Revised: February 28, 2025
Accepted: March 10, 2025
Published online: April 14, 2025
Processing time: 159 Days and 13.9 Hours
Core Tip
Core Tip: Post-endoscopic submucosal dissection esophageal stricture significantly affects patients' quality of life; however, current treatment options are inadequate to meet clinical demands. In this letter, we first examine the limitations of existing treatment methods for esophageal stricture. We then introduce the novel therapeutic agent Kangfuxin solution and elucidate its mechanisms of action. Finally, we explore some emerging treatment technologies and propose potential avenues for future research.